A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.

Completed

• Conditions: Bowel Cleanliness
• Interventions: Drug: sodium picosulphate

• Registration Number: NCT01292109
• Lead Sponsor: Ferring Pharmaceuticals

Brief Summary

The study serves as a confirmation of safety, tolerance and efficacy of PICOPREP in clinical practice.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-12
• Study First Submitted: 2011-02-08
• Study First Submitted QC: 2011-02-08
• Study First Posted: 2011-02-09
• Primary Completion: 2011-09
• Status Verified: 2012-02
• Study Completion: 2012-02
• Last Update Submitted: 2012-02-08
• Last Update Posted: 2012-02-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 252

Inclusion Criteria

• Patients receiving PICOPREP® for bowel evacuation prior to endoscopy or surgery

Exclusion Criteria

• Patients in which prescription of PICOPREP® is contraindicated

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
PICOPREP®	sodium picosulphate	-

Primary Outcome Measures

Name	Time	Method
Documentation of use PICOPREP in everyday practice	Day 0 - 2

Secondary Outcome Measures

Name	Time	Method
Participant satisfaction and compliance after bowel cleansing	Days 0-2
Participants with adverse events reported by frequency and severity	Days 1-2

Trial Locations

Locations (2)

University Hospital; 🇨🇿 Pilsen, Czech Republic

Iscare - Prague 7; 🇨🇿 Prague 7, Czech Republic